Gastrointestinal safety of coxibs and outcomes studies: What's the verdict?

Journal of Pain and Symptom Management

Volumn 23, Issue 4 SUPPL. 1, 2002, Pages S5-

  Laine, Loren ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Celecoxib; COX 2 inhibitors; Coxibs; Gastrointestinal; Rofecoxib; Safety

Indexed keywords

CELECOXIB; DICLOFENAC; IBUPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB;

CLINICAL TRIAL; CONFERENCE PAPER; DIGESTIVE SYSTEM INJURY; DRUG SAFETY; GASTROINTESTINAL TRACT; HUMAN; INCIDENCE; OSTEOARTHRITIS; OUTCOMES RESEARCH; RHEUMATOID ARTHRITIS; RISK FACTOR; TREATMENT OUTCOME; ULCER;

EID: 0036242993     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(02)00368-8     Document Type: Conference Paper

References (13)

1. 2) synthesis in healthy humans
2. A randomized trial measuring fecal blood loss after treatment with rofecoxib, ibuprofen, or placebo in healthy subjects
3. COX-2 specific inhibition with MK-0966 25 or 50 mg Q.D. does not increase intestinal permeability: A controlled study with placebo (PBO) and indomethacin 50 mg T.I.D (INDO)
4. A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis
5. Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial
6. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: A randomized controlled trial
7. Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: Randomised double-blind comparison
8. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. The CLASS study: A randomized controlled trial
9. For the VIGOR Study Group. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
10. Prophylactic aspirin and risk of peptic ulcer bleeding
11. Gauging the impact of statins using number needed to treat
12. Risk factors for serious gastrointestinal complications related to use of nonsteroidal antiinflammatory drugs: A meta-analysis